Related Experiment Video
Updated: Jul 8, 2026
10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
46.5K
Surgical decompression for malignant cerebral oedema after ischaemic stroke
Ashraf Dower1,2, Michael Mulcahy3, Monish Maharaj4
1Liverpool Hospital, Liverpool, Australia.
The Cochrane Database of Systematic Reviews
|November 17, 2022
Summary
Early surgical decompression significantly reduces mortality and severe disability in patients with malignant stroke edema. This intervention improves outcomes for stroke patients, including those over 60, but careful consideration of patient prognosis is essential.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Large territory middle cerebral artery (MCA) ischaemic strokes with malignant oedema have a poor prognosis.
- Cerebral oedema causes increased intracranial pressure, leading to secondary brain damage.
- Early decompressive craniectomy can alleviate pressure and improve outcomes.
Purpose of the Study:
- To assess the effectiveness of surgical decompression in reducing mortality and improving functional outcomes in malignant oedema after ischaemic stroke.
- To examine the adverse effects of surgical decompression in this patient cohort.
Main Methods:
- Searched multiple databases (Cochrane, MEDLINE, Embase, etc.) up to July 2022.
- Included randomized controlled trials (RCTs) comparing decompressive craniectomy with medical management.
- Assessed primary outcomes of death and death or severe disability (modified Rankin Scale > 4) at 6-12 months.
Main Results:
- Nine RCTs with 513 participants were included.
- Surgical decompression significantly reduced death (OR 0.18) and death or severe disability (OR 0.22) (high-certainty evidence).
- Benefits were observed in patients over 60, though they have a poorer prognosis.
Conclusions:
- Surgical decompression improves outcomes in malignant oedema after ischaemic stroke.
- The treatment significantly reduces death or severe disability (mRS > 4) and death or moderate disability (mRS > 3).
- Benefits extend to older patients, but their overall prognosis must be considered.
